Helen Harrison

Helen Harrison has a diverse work experience spanning several companies. Helen is currently working as the Director of Discovery Biology at STORM Therapeutics Limited, starting in February 2023. Prior to this, they held the position of Director of Screening at Amphista Therapeutics Limited from August 2021 to February 2023.

Helen also worked at Bicycle Therapeutics, where they held multiple roles. These include Director, Assay Biology from December 2020 to August 2021, Group Leader from December 2018 to December 2020, and Assay Biology Team Leader from July 2010 to December 2018.

Before joining Bicycle Therapeutics, they worked as a Research Scientist at Takeda from August 2005 to June 2010. Helen started their professional journey as an Industrial Placement Student at GlaxoSmithKline from July 2003 to July 2004.

Helen Harrison pursued their education starting from 2001 to 2005 at the University of Leeds, where they completed their Bachelor of Science (BSc) degree in Medical sciences. Continuing their academic journey, from 2006 to 2009, they attended The Open University, where they obtained their Master of Science (MSc) degree in Science.